Fund Holdings — VR Adviser, LLC

Total Portfolio Value
$2.68B
Total Bought
$347.12M
Total Sold
$303.42M
Net Transaction
+$43.70M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ERASCA INC(ERAS)17,857,08316,382,812-1,474,27166,428265,0749.89%+198,646
DAMORA THERAPEUTICS INC(DMRA)03,603,595+3,603,595093,3333.48%+93,333
ORUKA THERAPEUTICS INC(ORKA)4,148,4284,148,4280125,739203,4807.60%+77,742
APOGEE THERAPEUTICS INC(APGE)8,493,3218,493,3210641,076714,88326.68%+73,807
SPYRE THERAPEUTICS INC(SYRE)3,685,4483,685,4480120,735185,8946.94%+65,159
DIANTHUS THERAPEUTICS INC(DNTH)1,000,0001,180,000+180,00041,21099,0263.70%+57,816
RELMADA THERAPEUTICS INC(RLMD)04,843,380+4,843,380033,7101.26%+33,710
VOR BIOPHARMA INC(VOR)1,943,7663,041,719+1,097,95325,42454,2642.03%+28,840
TENAX THERAPEUTICS INC(TENX)01,675,262+1,675,262026,7871.00%+26,787
ADLAI NORTYE LTD(ANL)03,212,731+3,212,731022,2320.83%+22,232
KALVISTA PHARMACEUTICALS INC6,728,9856,474,485-254,500108,673130,3314.86%+21,658
CENTURY THERAPEUTICS INC(IPSC)08,695,652+8,695,652019,6520.73%+19,652
ENLIVEN THERAPEUTICS INC3,226,3311,726,331-1,500,00049,68567,6722.53%+17,987
CRESCENT BIOPHARMA INC.(CBIO)2,133,5762,133,576025,30439,1941.46%+13,890
KORRO BIO INC(KRRO)01,009,500+1,009,500011,4280.43%+11,428
ALTO NEUROSCIENCE INC(ANRO)0500,000+500,000011,2400.42%+11,240
ZURA BIO LTD(ZURA)5,345,1156,434,990+1,089,87528,00838,2881.43%+10,280
ORIC PHARMACEUTICALS INC(ORIC)5,676,2304,319,765-1,356,46546,43254,7312.04%+8,300
COGENT BIOSCIENCES INC(COGT)2,000,0002,000,000071,04076,9802.87%+5,940
CULLINAN THERAPEUTICS INC(CGEM)1,379,9651,379,965014,28319,6090.73%+5,327
SURROZEN INC(SRZN)632,931632,931014,30418,4370.69%+4,133
ARTIVA BIOTHERAPEUTICS INC(ARTV)1,609,5691,609,56906,90510,3660.39%+3,461
X4 PHARMACEUTICALS INC(XFOR)0330,525+330,52501,3650.05%+1,365
CASI PHARMACEUTICALS INC(CASIF)987,2590-987,2598390—-839
OCULAR THERAPEUTIX INC(OCUL)7,315,54710,346,926+3,031,37988,81187,6383.27%-1,172
DYNE THERAPEUTICS INC(DYN)2,173,9132,173,913042,52239,4131.47%-3,109
JADE BIOSCIENCES INC3,220,3643,220,364049,69045,2461.69%-4,444
SEPTERNA INC(SEPN)610,808506,056-104,75217,02912,1610.45%-4,869
SAVARA INC(SVRA)13,740,37513,740,375082,85475,0222.80%-7,832
ENGENE HOLDINGS INC
COM
4,771,4144,771,414043,08632,4931.21%-10,593
CYBIN INC(HELP)3,840,2503,851,654+11,40431,41318,4880.69%-12,925
MAZE THERAPEUTICS INC(MAZE)1,548,5691,602,034+53,46564,15747,8211.78%-16,336
CYTOMX THERAPEUTICS INC(CTMX)15,561,5009,982,124-5,579,37666,29246,9161.75%-19,376
UPSTREAM BIO INC(UPB)1,169,2980-1,169,29831,7460—-31,746
VIRIDIAN THERAPEUTICS INC(VRDN)3,882,7093,882,7090120,83075,9462.83%-44,884
Page 1 of 1
VR Adviser, LLC — 13F Holdings — Q1 2026 | TickerTrail